In localized and de novo metastatic prostate cancer, three genes, DOCK2, HAPLN3, and FBXO30, were found to be specifically hypermethylated in prostate cancer tissues using MS‐ddPCR [44]. The gene discussed is HAPLN3; the disease is prostate carcinoma.